The intermittent catheters market size is projected to reach US$ 3.83 billion by 2031 from US$ 2.67 billion in 2023. The market is expected to register a CAGR of 4.6% during 2023–2031. The introduction of micro-hole zone catheters is likely to remain a key trend in the intermittent catheters market.
Urinary incontinence (UI) is the most common problem affecting a substantial global population. It results in occasional or minor leaking or uncontrolled chronic urination, in worse cases. The growing prevalence of obesity; the increasing geriatric population; and the rising incidence of chronic diseases such as prostate cancer, diabetes, kidney diseases, and multiple sclerosis are among the prime risk factors for UI. Medical conditions such as spinal cord injuries, cerebral palsy, prostate enlargement, multiple sclerosis, and cancer, among others, may lead to UI in the geriatric population. Thus, the rising prevalence of UI is driving the growth of the intermittent catheters market
The awareness of urinary incontinence and its impact on the quality of life is increasing across the world. As awareness grows, more people seek medical care and alternatives, such as intermittent catheters, to control their illnesses. Intermittent catheters are most commonly used by patients with spinal cord injuries or urine incontinence. These catheters are made from latex rubber, polyvinyl chloride (PVC) or vinyl, and silicone, and are intended for single use. Silicone is thought to be one of the most biocompatible materials for catheter manufacture.
Single-use intermittent catheters have been linked with improved health outcomes, including a lower risk of urinary tract infections (UTIs), urethral trauma, and quality of life. The use of single-use catheters for intermittent catheterization reduces the risk of short and long-term problems. Single-use intermittent catheters are highly recommended for patients with recurring UTIs. Moreover, they are a preferred option in many patients due to the convenience of use. Modern single-use catheters are designed to be inserted with proper safety and sterility measures using applicators, or they may be offered with an extra protective coating. According to NIH, in most European countries, almost every patient uses a single-use catheter. Further, there are no regulatory foundations or evidence-based outcomes available that recommend the reuse or multiple use of catheters for intermittent catheterization. Thus, the adoption of single-use intermittent catheters is on the rise due to the reduced possibility of infections, and better sterility and lubrication measures. Otsuka Pharmaceutical, Coloplast, and Boston Scientific Corp are among the companies providing single-use intermittent catheters. Thus, the rising adoption of single-use intermittent catheters drives the growth of the intermittent catheters market.
Benign prostatic hyperplasia (BPH) and prostatitis are among the most common reasons for intermittent self-catheterization in men. Many women face difficulties in bladder control, which compels them to opt for intermittent self-catheterization, which assists them to lead a normal life. For instance, Actreen Mini Cath (B.Braun) is a short urinary catheter designed for female self-catheterization. It is an easy and ready-to-use catheter with a feminine and modern design. Intermittent self-catheterization allows greater independence and personal control in patients over their long-term bladder conditions. Intermittent self-catheterization is also likely to contribute to a positive assessment of quality of life and increased self-esteem. Moreover, a clean intermittent self-catheterization (CISC) is now considered the gold standard for the management of urinary retention. Companies in the catheter market are increasingly investing in efforts to introduce newer products. For example, in December 2020, Ingenion Medical Ltd received ~US$ 135,772 (GBP 100,000) in funding from Innovative UK to develop their CymActive urinary catheters. It is a revolutionary medical device intended to treat male patients suffering from urine retention. Thus, the increasing preference for self-catheterization and investments in urinary catheter developments are likely to create significant growth opportunities in the market in the coming years.
Key segments that contributed to the derivation of the intermittent catheters market analysis are product, indication, category, system type, and end user.
The geographic scope of the intermittent catheters market report encompasses five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America dominated the intermittent catheters market in 2023. A surge in the geriatric population affected by various types of urinary diseases, favorable reimbursement policies for catheterization, an increase in the number of hospitals and clinics, and a rise in healthcare expenditure and technological developments are a few factors propelling the market growth in the region.
The regional trends and factors influencing the Intermittent Catheters Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Intermittent Catheters Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 2.67 Billion |
| Market Size by 2031 | US$ 3.83 Billion |
| Global CAGR (2023 - 2031) | 4.6% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Intermittent Catheters Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Intermittent Catheters Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The intermittent catheters market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the market are mentioned below:
The “Intermittent Catheters Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering the following areas:
The market is estimated to grow at a CAGR of 4.6% during 2023–2031.
The estimated value of the market by 2031 will be US$ 3.83 billion.
Coloplast Corp, Hollister Inc, and Cardinal Health Inc are the leading players operating in the intermittent catheters market.
The micro-holes zone catheters is likely to act as future trends in the market in the future.
The rising prevalence of chronic and infectious diseases, and the increasing number of clinical trials are the factors bolstering the market
North America dominated the market in 2023.